Prot# IDEC 114-20: A Phase I/II Trial of Anti-CD80 Monoclonal Antibody (IDEC-114) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date4/23/02 → 1/1/11

Funding

  • IDEC Pharmaceuticals Corporation (IDEC 114-20)